Cartilage Defect Study
-
Biologics
AlloSource Announces First Patient Enrolled In ProChondrix CR Cartilage Defect Study
CENTENNIAL, Colo., March 20, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue,…
Read More »